Dr Helen Allars, Chairperson, Datapharm Australia Pty Ltd
Helen has always had a passion for medical research. She majored in Biochemistry and Chemistry and was the first Science student to do Honours in Cell Pathology at Sydney University. She followed this up with a Masters in Cell Pathology, conducting cystic fibrosis research at Children’s Medical Research Foundation (CMRF). A few years in the Clinical Pharmacology Department at St Vincent’s Hospital, mentored by Prof Denis Wade, saw Helen awarded a PhD for research into phospholipid turnover in dopamine receptors in guinea pig striatal nerve endings.
Helen spent some time teaching pharmacology at UNSW before the pharmaceutical industry lured her with a role as a CRA at SmithKline & French. Helen’s interest in statistics and collection of clinical data saw the introduction of the first computer into the SKF medical department. Family commitments encouraged Helen to work from home as a consultant while she studied statistics.
As clients became more plentiful, Helen was able to take on staff and Datapharm Australia was born in 1987. Since then, she has managed and mentored a diverse and enthusiastic team. As the company expanded, so have Helen’s abilities and today the company continues to thrive under her care as Managing Director.
Lyn Tozer - Medical Director, MBBS, MHA
A medical graduate of the University of Sydney, Lyn spent many years in hospital and general practice roles before joining Datapharm in 1994 while completing her MHA (Master of Health Administration) at UNSW. Over the years Lyn has experienced all facets of clinical trial management and data management in her life at Datapharm. For several years she oversaw clinical monitoring services and in 2005 became the Medical Director. Since 2007 Lyn has managed Datapharm’s team of medical and scientific writers and has had responsibility for the company’s pharmacovigilance services. In 2008 Lyn undertook general practice retraining through the University of Sydney in order to update her clinical knowledge, skills which have proven advantageous in her current role at Datapharm.
Jim Sockler - Manager of Programming & Statistics, PhD
Texas born and bred, Jim taught sports physiology for some years at Colorado State University before coming to Australia in 1991 to become Assoc Prof and head of school at UNSW department of sport and leisure studies. In 1999 Jim became Principal at the Australian College of Physical Education (ACPE) at Homebush where he remained until 2003 when he left academia to pursue a career in statistics, a subject he had taught for over 20 years. He came to Datapharm in 2005 where, as Manager of Statistical Operations and Programming, he has a team of statisticians and programmers to guide, organise and teach. The team is well integrated and organised and the smooth operation of multiple projects is the norm under Jim’s expert care.
Dr Howard Geldard – Quality Manager & GCP Compliance Auditor
Dr Geldard graduated as a Veterinarian from Sydney University and has worked in every aspect of both veterinary and medical clinical trials since. He has been responsible for many advances in the development of key animal and human pharmaceuticals and has held senior management positions with Squibb, Glaxo UK, IDT and Datapharm Australia. He has worked in clinical trials in over 16 countries throughout Europe, Africa and Asia-Pacific. Dr Geldard is now working as Datapharm Australia’s Quality Manager & GCP Compliance Auditor.
Luke Edington- Senior CRA & Project Manager
University of Sydney Honours Graduate in Pharmacology, also studied International Business, with a focus on marketing and international business strategy.
Luke started at Datapharm Australia as a graduate, progressing in the clinical department as a CTA, CRA, Lead CRA, CCRA to Senior CRA , Project Manager and Head of the Monitoring Team. Luke now has some years experience managing projects with an eclectic mix of clients and therapeutic areas.
Luke has a passion for achieving goals, enjoys working with like minded people, and gains satisfaction from solving Sponsors’ challenges. Luke also plays a role in business development activities for Datapharm Australia.
Frances Scroope - Monitors’ Support Manager/ Senior CRA
After graduating from Sydney University with a Bachelor of Education degree, Frances commenced her nursing training at the Royal North Shore Hospital in Sydney. She was able to combine her experience in Education and Nursing when she took on the role of Clinical Educator for the Post Graduate Cardiothoracic Course at the hospital in 1989. Frances’ next role as a Study Coordinator introduced her to the world of Clinical Research and from there to a CRA role at Roche Products Pty Ltd.
Having gained valuable experience as a Senior CRA at Roche, Frances commenced at Datapharm in 2007.
She now uses her now uses her English Literature, Clinical and Research backgrounds to mentor, train and support the monitoring team.
Marinella Messina, PhD - Senior Scientist & Senior CRA
Marinella has pursued an academic research career since 1989 after completing a science degree (BSc. Hons, University of Sydney). She has worked on a number of research projects from developing genetic tools to study of bacterial and parasitic disease, at the Washington University Medical School, USA, to research work in Endocrine and Neural cancer at the Kolling Institute of Medical Research, Australia. She gained her PhD in 2002 (University of Sydney) and held a research position at the Royal North Shore Hospital Sydney as Senior Hospital Scientist. In 2009 she left academic research to pursue a career in clinical research working at Datapharm Australia, as a medical writer and Clinical Research Associate. She is a Certified Medical Publication Professional (CMPP). In these capacities she has been involved in a number of Phase I to Phase III trials in a variety of therapeutic areas at Datapharm Australia.
Now as a Senior Scientist and Senior Clinical Research Associate, Marinella has managed two early phase studies from protocol writing and assistance with study design, ongoing IB updates to clinical trial set up with document preparation for local regulatory submissions and monitoring, to final clinical study report production. In particular she has established an ongoing partnership with the scientific research team at the centre for vascular disease, UNSW, in their development of a novel drug for skin cancers and ocular disease by assisting them with the translation of their basic research to the early clinical studies. In her capacity as a medical writer and as a CMPP she has supported them with manuscript preparation and in funding applications. She also assists in pharmacovigilance for Datapharm Australia and is training in auditing of clinical studies.